Literature DB >> 10072667

Effect of two antidepressant drugs on REM sleep and EMG activity during sleep.

M Jobert1, P Jähnig, H Schulz.   

Abstract

In a placebo-controlled study, the effects on sleep of single and repeated doses of imipramine and dexnafenodone, an antidepressant drug under development, were investigated in young, healthy volunteers. In contrast to placebo, both drugs suppressed REM sleep substantially after acute and repeated administration. As a consequence, REM sleep latencies increased under active treatment to mean values which were about two to four times larger than baseline values. Since the active inhibition of the muscle tone is a distinct feature of REM sleep, we studied the influence of the two antidepressant drugs on this variable. By means of computerised EMG analysis, tonic and transient EMG activity were computed for total recording time and for the different sleep stages. While tonic EMG activity during sleep was increased with both drugs, transient EMG events remained unaffected. Computerised analysis of the microstructure of sleep is an effective tool for studying the effect of antidepressant drugs on sleep.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072667     DOI: 10.1159/000026568

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  6 in total

Review 1.  Antidepressants and sleep: a qualitative review of the literature.

Authors:  Sue Wilson; Spilios Argyropoulos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat.

Authors:  Raymond Cespuglio; Colette Rousset; Gabriel Debilly; Catherine Rochat; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  Antidepressant effects of selective slow wave sleep deprivation in major depression: a high-density EEG investigation.

Authors:  Eric C Landsness; Michael R Goldstein; Michael J Peterson; Giulio Tononi; Ruth M Benca
Journal:  J Psychiatr Res       Date:  2011-03-11       Impact factor: 4.791

Review 4.  [Sleeping behaviour and headache attacks in cases of primary headache. Possible pathological mechanisms].

Authors:  A Straube; S Förderreuther
Journal:  Schmerz       Date:  2004-08       Impact factor: 1.107

5.  Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light.

Authors:  Jana Tchekalarova; Lidia Kortenska; Natasha Ivanova; Milena Atanasova; Pencho Marinov
Journal:  Psychopharmacology (Berl)       Date:  2019-11-13       Impact factor: 4.530

6.  Duloxetine-induced rapid eye movement sleep behavior disorder: a case report.

Authors:  Lu Tan; Junying Zhou; Linghui Yang; Rong Ren; Ye Zhang; Taomei Li; Xiangdong Tang
Journal:  BMC Psychiatry       Date:  2017-11-21       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.